Bruker Announces Preliminary Second Quarter 2012 Revenue and EPS, as well as Planned Earnings Release Date
24 July 2012 - 8:30PM
Business Wire
Bruker Corporation (NASDAQ: BRKR) announced today that based
upon preliminary financial data the Company expects total second
quarter 2012 revenue of approximately $420 million, compared to
second quarter 2011 revenue of $401.2 million.
For the second quarter of 2012, Bruker expects to report GAAP
EPS in the range of $0.05 - $0.07, and adjusted EPS in the range of
$0.11 - $0.13. The Company’s financial results in the second
quarter of 2012 were adversely impacted by a weaker Euro, softening
customer demand, especially in Europe, and an increase in spending.
Bruker will provide commentary on its financial results and an
updated financial outlook for 2012 in its earnings release on July
31st, 2012.
Bruker to Host Second Quarter Conference Call on July 31,
2012
Bruker Corporation plans to release its second quarter 2012
financial results on Tuesday, July 31st, 2012 before the market
opens. Bruker will then host an operator-assisted earnings
conference call that morning at 9:00 AM Eastern Daylight Time. To
listen to the webcast, investors can go to http://ir.bruker.com and
click on the live web broadcast symbol. The webcast will be
available through the Company web site for 30 days.
Investors can also listen and participate on the telephone in
the US and Canada by calling 800-688-0796, or +1-617-614-4070
outside the US and Canada. Investors should refer to the Bruker
Earnings Call. A telephone replay of the conference call will be
available approximately one hour after the conference call by
dialing 888-286-8010 in the US and Canada, or +1-617-801-6888
outside the US and Canada, and then entering replay pass code
75583008.
Use of Non-GAAP Financial Measures
In addition to the financial measures prepared in accordance
with generally accepted accounting principles (GAAP), we use
certain non-GAAP financial measures, including adjusted EPS, which
exclude amortization of acquisition-related intangible assets,
restructuring costs, and fees associated with legal compliance and
examinations. We exclude the above items because they are outside
of our normal operations and/or, in certain cases, are difficult to
forecast accurately for future periods. Specific quantifications of
the amounts that would be required to reconcile the range of
adjusted EPS to the range of GAAP EPS are not available at this
point in the closing process. Bruker will provide a detailed
reconciliation of GAAP and non-GAAP financial measures when it
reports earnings for the three and six months ended June 30, 2012
on Tuesday, July 31st, 2012. We believe that the use of non-GAAP
measures helps investors to gain a better understanding of our core
operating results and future prospects, consistent with how
management measures and forecasts the company’s performance,
especially when comparing such results to previous periods or
forecasts.
FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements
including, among other things, statements regarding Bruker’s
expected financial results for the quarter ended June 30, 2012.
These forward-looking statements are subject to the safe harbor
provisions created by the Private Securities Litigation Reform Act
of 1995. Actual results could differ materially from those
projected in the forward-looking statements. Bruker’s expectations
about its quarterly results are based on preliminary information
about the second quarter of 2012 and are subject to revision.
Although the quarter is now completed, Bruker is still in the early
stages of its standard financial reporting closing procedures.
Accordingly, as Bruker completes its normal quarter-end closing and
review processes, actual results could differ materially from its
preliminary estimates. Factors that could cause Bruker’s actual
results to differ materially from those contemplated by these
forward-looking statements include, among others: inaccurate data
or assumptions; unforeseen expenses; changes in estimates or
judgments related to tax liabilities; potential goodwill
impairments; potential litigation, bad debts or other
contingencies; and facts or circumstances affecting the application
of Bruker’s critical accounting policies, including revenue
recognition. These forward looking statements are based on current
expectations and are subject to uncertainties and changes in
condition, significance, value and effect as well as other risks
detailed in documents filed with the Securities and Exchange
Commission, including our most recent reports on Form 10-K and Form
10-Q and current reports on Form 8-K that we may file from time to
time, which could cause actual results to vary from expectations.
Bruker assumes no obligation to, and does not currently intend to,
update any such forward-looking statements after the date of this
release.
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024